FIVE PRIME THERAPEUTICS, INC. 3 SEC Filings

Filed On	Filing
08 Mar 2021	Form 3: Bvf Partners L P/IL, 10% owner and 9 others Holds 3,372,098 shares of Common Stock, $0.001 par value per share
18 May 2020	Form 3: Bvf Gp Holdings Llc, 10% owner and 2 others Holds 3,929,792 shares of Common Stock, $0.001 par value
14 Apr 2020	Form 3: Civik Thomas, Director No securities owned
02 Oct 2019	Form 3: Bvf Partners L P/IL, 10% owner and 6 others Holds 2,046,311 shares of Common Stock, $0.001 par value
25 Jun 2019	Form 3: Lyons-Williams Lori, Director No securities owned
16 May 2019	Form 3: Schafer Carol, Director No securities owned
04 Mar 2019	Form 3: White David, See Remarks No securities owned
27 Nov 2018	Form 3: Smith David V, Executive Vice President & CFO No securities owned
23 Apr 2018	Form 3: Rubinstein Linda M, Interim CFO No securities owned
05 Sep 2017	Form 3: Irving Bryan, SVP, Research No securities owned
12 May 2017	Form 3: Nicholson Garry A, Director No securities owned
22 Mar 2017	Form 3: Collins Helen Louise, SVP and Chief Medical Officer Holds 20,156.25 shares of Common Stock
12 Sep 2016	Form 3: Borges Luis, SVP, Research Holds 66,622 shares of Common Stock
03 Feb 2016	Form 3: Baker Kevin Paul, SVP, Development Sciences No securities owned
01 Feb 2016	Form 3: Sikorski Robert Steven, SVP, Global Clinical Develop. Holds 101,424 shares of Common Stock
03 Dec 2015	Form 3: Gujrathi Sheila, Director No securities owned
03 Dec 2015	Form 3: Dhingra Kapil, Director No securities owned
02 Sep 2015	Form 3: Adage Capital Partners Gp Llc, 10% owner and 4 others Holds 2,664,949 shares of Common stock, par value $0.001
24 Jun 2015	Form 3: Wong Brian Russell, SVP, Research Holds 22,738 shares of Common Stock
02 Oct 2014	Form 3: Ringo William R, Director No securities owned

Comments